In addition, increased BRG1 levels have been associated with reduced inflammatory responses and decreased oxidative damage in cerebral ischemia–reperfusion injury, and BRG1 deficiency has been linked to inflammation-driven colorectal cancer [8, 34]. This evidence concerns the gene SMARCA4 and colorectal cancer.